Six new public issues, including Mahamaya Lifesciences, Shining Tools, Curis Lifesciences, Finance Buddha, and Shreeji Global FMCG, are set to launch on Dalal Street this week, collectively targeting over ₹10,700 crore. Market analysts highlight that these listings span healthcare, fintech, and consumer sectors, reflecting diversified investor opportunities. Subscription trends, pricing, and valuation multiples will be closely watched by investors. These IPOs are expected to gauge market sentiment, especially amid current equity trends and retail participation. Experts emphasize careful assessment of fundamentals and growth prospects before investing.

Kore.ai raised $150 million in funding to scale its enterprise generative AI platforms, focusing on enhanced natural language processing, chatbot development, and business automation solutions. The funding round, led by prominent investors, aims to accelerate R&D, expand the product portfolio, and enhance deployment for enterprise clients globally. Analysts predict this will strengthen Kore.ai’s competitive position, drive adoption across sectors, and facilitate AI-driven operational efficiency. The capital injection underscores investor confidence in enterprise AI and the growing demand for intelligent automation and conversational AI services worldwide.